NCT07487623

Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

Evaluation of the Hepatoprotective Effects of a Nutritional Supplement Containing Resveratrol, Quercetin, Taurine, Inulin, and Whey Protein on Biochemical, Molecular, and Clinical Markers in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 26 (estimated)
• Sponsor: University of Guadalajara · Academic / Other
• Sex: All
• Age: 18 Years – 69 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this clinical trial is to evaluate whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein improves biochemical and molecular markers, as well as clinical outcomes, in patients with liver disease related to chronic hepatitis C infection. The study will compare the investigational supplement with an active control (whey protein alone) to determine whether the combination formulation provides additional benefits on liver-related biomarkers and clinical assessment. Participants will: Take the investigational supplement or active control daily for 12 weeks. Attend clinic visits every 4 weeks for laboratory testing and clinical evaluations.

Conditions

• Liver Disease Chronic
• HEPATITIS C VIRUS CHRONIC INFECTION

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	resveratrol, quercetin, taurine, whey protein, and inulin	powdered supplement containing resveratrol, quercetin, taurine, whey protein, and inulin
DIETARY_SUPPLEMENT	whey protein	powdered supplement containing whey protein

Timeline

• Start date: 2025-10-11
• Primary completion: 2026-03-31
• Completion: 2026-05-15
• First posted: 2026-03-23
• Last updated: 2026-03-23

Locations

2 sites across 1 country: Mexico